Drugs / MF59-adjuvanted TIV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01210898 | Sep 2010 → Jan 2011 | influenza | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-adjuvanted TIV | “trivalent inactivated influenza vaccine (TIV) versus MF59-adjuvanted TIV (aTIV) in children” PMID 26091244 ↗ 2015 |
| Known as | aTIV | “trivalent inactivated influenza vaccine (TIV) versus MF59-adjuvanted TIV (aTIV) in children” PMID 26091244 ↗ 2015 |
| Modality | Vaccine | “trivalent inactivated influenza vaccine (TIV)” PMID 26091244 ↗ 2015 |
| Route | Intramuscular | “Following a Single Intramuscular Dose of a Sub-unit Adjuvanted or a Non-adjuvanted Influenza Vaccines” NCT01210898 ↗ |